Cargando…
Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins
Either acute or sub-acute Budd–Chiari syndrome (BCS) with diffuse occlusion of hepatic veins has a high mortality rate and remains challenging for clinical treatment. We aimed to evaluate the feasibility and safety of transjugular intrahepatic portosystemic shunt (TIPS) as a treatment for BCS with d...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090639/ https://www.ncbi.nlm.nih.gov/pubmed/27805025 http://dx.doi.org/10.1038/srep36380 |
_version_ | 1782464425434808320 |
---|---|
author | He, Fuliang Zhao, Hongwei Dai, Shan Wu, Yingfeng Wang, Lei Huang, Hongdong Yue, Zhendong Fan, Zhenhua Dong, Xiaoqun Liu, Fuquan |
author_facet | He, Fuliang Zhao, Hongwei Dai, Shan Wu, Yingfeng Wang, Lei Huang, Hongdong Yue, Zhendong Fan, Zhenhua Dong, Xiaoqun Liu, Fuquan |
author_sort | He, Fuliang |
collection | PubMed |
description | Either acute or sub-acute Budd–Chiari syndrome (BCS) with diffuse occlusion of hepatic veins has a high mortality rate and remains challenging for clinical treatment. We aimed to evaluate the feasibility and safety of transjugular intrahepatic portosystemic shunt (TIPS) as a treatment for BCS with diffuse occlusion of hepatic veins. From January 2007 to December 2010, 100 patients were randomly recruited onto this study and 91 patients were treated with TIPS. 14 patients were defined as acute BCS group and 86 patients as sub-acute group. Patients with acute BCS had a significantly higher rate of jaundice whereas a lower rate of abdominal and chest varices, gastroesophageal variceal bleeding and refractory ascites than sub-acute group (P < 0.001). TIPS was technically successful in all 91 patients (12 in acute group). The portosystemic pressure gradient (PSG) was decreased to normal level, while total bilirubin (TBIL) and liver function were significantly improved. During follow-up period, the mortality rate of 91 patients who underwent TIPS was 6.59% (6/91), whereas 88.89% of 9 patients who didn’t receive TIPS procedure (2 in acute group). Collectively, TIPS is an effective and safe approach in treating BCS with diffuse occlusion of hepatic veins, which should be performed in time. |
format | Online Article Text |
id | pubmed-5090639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50906392016-11-08 Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins He, Fuliang Zhao, Hongwei Dai, Shan Wu, Yingfeng Wang, Lei Huang, Hongdong Yue, Zhendong Fan, Zhenhua Dong, Xiaoqun Liu, Fuquan Sci Rep Article Either acute or sub-acute Budd–Chiari syndrome (BCS) with diffuse occlusion of hepatic veins has a high mortality rate and remains challenging for clinical treatment. We aimed to evaluate the feasibility and safety of transjugular intrahepatic portosystemic shunt (TIPS) as a treatment for BCS with diffuse occlusion of hepatic veins. From January 2007 to December 2010, 100 patients were randomly recruited onto this study and 91 patients were treated with TIPS. 14 patients were defined as acute BCS group and 86 patients as sub-acute group. Patients with acute BCS had a significantly higher rate of jaundice whereas a lower rate of abdominal and chest varices, gastroesophageal variceal bleeding and refractory ascites than sub-acute group (P < 0.001). TIPS was technically successful in all 91 patients (12 in acute group). The portosystemic pressure gradient (PSG) was decreased to normal level, while total bilirubin (TBIL) and liver function were significantly improved. During follow-up period, the mortality rate of 91 patients who underwent TIPS was 6.59% (6/91), whereas 88.89% of 9 patients who didn’t receive TIPS procedure (2 in acute group). Collectively, TIPS is an effective and safe approach in treating BCS with diffuse occlusion of hepatic veins, which should be performed in time. Nature Publishing Group 2016-11-02 /pmc/articles/PMC5090639/ /pubmed/27805025 http://dx.doi.org/10.1038/srep36380 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article He, Fuliang Zhao, Hongwei Dai, Shan Wu, Yingfeng Wang, Lei Huang, Hongdong Yue, Zhendong Fan, Zhenhua Dong, Xiaoqun Liu, Fuquan Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title | Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title_full | Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title_fullStr | Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title_full_unstemmed | Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title_short | Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins |
title_sort | transjugular intrahepatic portosystemic shunt for budd–chiari syndrome with diffuse occlusion of hepatic veins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090639/ https://www.ncbi.nlm.nih.gov/pubmed/27805025 http://dx.doi.org/10.1038/srep36380 |
work_keys_str_mv | AT hefuliang transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT zhaohongwei transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT daishan transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT wuyingfeng transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT wanglei transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT huanghongdong transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT yuezhendong transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT fanzhenhua transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT dongxiaoqun transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins AT liufuquan transjugularintrahepaticportosystemicshuntforbuddchiarisyndromewithdiffuseocclusionofhepaticveins |